Connection
Michele Fox to Drug Resistance
This is a "connection" page, showing publications Michele Fox has written about Drug Resistance.
|
|
Connection Strength |
|
|
|
|
|
0.021 |
|
|
|
-
Przepiorka D, Phillips GL, Ratanatharathorn V, Cottler-Fox M, Sehn LH, Antin JH, LeBherz D, Awwad M, Hope J, McClain JB. A phase II study of BTI-322, a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease. Blood. 1998 Dec 01; 92(11):4066-71.
Score: 0.021